

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.92495569 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.92495569 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.66349219 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.66349219 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.66349219 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.66349219 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.66349219 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.66349219 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.64882863 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.50401937 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.42802772 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.33933536 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.29905942 |
| 14 | detection of other organism (GO:0098543) | 5.13183068 |
| 15 | detection of bacterium (GO:0016045) | 5.06055252 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.91816661 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87469379 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.84328238 |
| 19 | response to peptidoglycan (GO:0032494) | 4.81175629 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.70480439 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.49191729 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.47374330 |
| 23 | leukocyte aggregation (GO:0070486) | 4.36652373 |
| 24 | respiratory burst (GO:0045730) | 4.30120481 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.27139514 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15426600 |
| 27 | type I interferon signaling pathway (GO:0060337) | 4.07977072 |
| 28 | cellular response to type I interferon (GO:0071357) | 4.07977072 |
| 29 | response to type I interferon (GO:0034340) | 4.04252279 |
| 30 | neutrophil activation (GO:0042119) | 4.03504175 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93288900 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92875671 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.92583290 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.89127892 |
| 35 | response to host immune response (GO:0052572) | 3.89127892 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.88493600 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.84790386 |
| 38 | granulocyte activation (GO:0036230) | 3.82294577 |
| 39 | cellular extravasation (GO:0045123) | 3.80015470 |
| 40 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.77775920 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.72853740 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.72248182 |
| 43 | B cell mediated immunity (GO:0019724) | 3.70776019 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.68389715 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.65190930 |
| 46 | defense response to protozoan (GO:0042832) | 3.64495529 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.64355874 |
| 48 | response to host (GO:0075136) | 3.54348694 |
| 49 | response to host defenses (GO:0052200) | 3.54348694 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.54348694 |
| 51 | microglial cell activation (GO:0001774) | 3.51144853 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.49167972 |
| 53 | germinal center formation (GO:0002467) | 3.49160332 |
| 54 | response to interleukin-15 (GO:0070672) | 3.48732401 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.46380866 |
| 56 | regulation of antigen processing and presentation (GO:0002577) | 3.40870168 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.40089488 |
| 58 | macrophage activation (GO:0042116) | 3.39602930 |
| 59 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.37843181 |
| 60 | positive regulation of interferon-alpha production (GO:0032727) | 3.35942595 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.33537340 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30867887 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 3.30477924 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.29955077 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.29545962 |
| 66 | response to protozoan (GO:0001562) | 3.29380782 |
| 67 | regulation of interferon-alpha production (GO:0032647) | 3.27316262 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23527474 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 3.23345616 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 3.22095652 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.20225955 |
| 72 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19974567 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.19287603 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.18106775 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.17824820 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16760985 |
| 77 | NIK/NF-kappaB signaling (GO:0038061) | 3.16744958 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14901299 |
| 79 | negative regulation of phagocytosis (GO:0050765) | 3.11343375 |
| 80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07803172 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 3.05991093 |
| 82 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04750982 |
| 83 | T-helper 1 type immune response (GO:0042088) | 3.04086405 |
| 84 | T cell migration (GO:0072678) | 3.02548764 |
| 85 | positive thymic T cell selection (GO:0045059) | 3.01766748 |
| 86 | regulation of tolerance induction (GO:0002643) | 3.00588123 |
| 87 | leukocyte degranulation (GO:0043299) | 3.00561848 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99941176 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.99755566 |
| 90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95819834 |
| 91 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92312143 |
| 92 | myeloid leukocyte mediated immunity (GO:0002444) | 2.91489078 |
| 93 | negative regulation of innate immune response (GO:0045824) | 2.91197545 |
| 94 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.90731368 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90104550 |
| 96 | positive regulation of mast cell degranulation (GO:0043306) | 2.90104550 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 2.87774629 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.87552582 |
| 99 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86081086 |
| 100 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.86067822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.10769345 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.54571289 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.46952084 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57860606 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37574417 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23441930 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20319796 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19638966 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16889086 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.98375974 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.84854841 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84844889 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79903896 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.70480012 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.68850371 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.68438544 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60169235 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59349330 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52871053 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.49044585 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.48315107 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.43546069 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37109396 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34071360 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31715262 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.22539629 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19947694 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18032135 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14957055 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.14222886 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13990812 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08448485 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05890423 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98735871 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.94791625 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93369361 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90247289 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87132891 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.81752054 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70873349 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70736674 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63512212 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62657683 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62604503 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62533654 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62430912 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62287130 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60423972 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56916288 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53360121 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53277820 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50418854 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48300364 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47883023 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45715372 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44714635 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43689904 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36692348 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34618346 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33973446 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32269326 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31018353 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30831321 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29242477 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28518679 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27995683 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27750161 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27398191 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24521217 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24302883 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21863119 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21832583 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21554145 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19642089 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19401409 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18997117 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17924506 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17634133 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17135052 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16700345 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16063311 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14299353 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13751386 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10980194 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05445171 |
| 86 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02386569 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01949503 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95585838 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94937615 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93611452 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92988832 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92961204 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91883092 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91697217 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87586607 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86436765 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85946495 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83918148 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82840710 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79097826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.33075830 |
| 2 | MP0003436_decreased_susceptibility_to | 4.22775032 |
| 3 | MP0003303_peritoneal_inflammation | 4.19492693 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.97663503 |
| 5 | MP0001790_abnormal_immune_system | 3.37714522 |
| 6 | MP0005387_immune_system_phenotype | 3.37714522 |
| 7 | MP0005671_abnormal_response_to | 3.28507470 |
| 8 | MP0009785_altered_susceptibility_to | 3.19785864 |
| 9 | MP0001800_abnormal_humoral_immune | 3.18373692 |
| 10 | MP0002419_abnormal_innate_immunity | 3.16506033 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.09486484 |
| 12 | MP0000685_abnormal_immune_system | 3.08459253 |
| 13 | MP0005025_abnormal_response_to | 3.02351626 |
| 14 | MP0002723_abnormal_immune_serum | 2.78054936 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.75643159 |
| 16 | MP0006082_CNS_inflammation | 2.74734433 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.67719723 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.65302594 |
| 19 | MP0001819_abnormal_immune_cell | 2.62670497 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.44510418 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.11643024 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.07848587 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.02683948 |
| 24 | MP0002405_respiratory_system_inflammati | 2.01207462 |
| 25 | MP0002398_abnormal_bone_marrow | 1.97221277 |
| 26 | MP0000716_abnormal_immune_system | 1.96722518 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.95823522 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.91530252 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.89829909 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.87131978 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.84212978 |
| 32 | MP0004510_myositis | 1.80164496 |
| 33 | MP0004947_skin_inflammation | 1.74295749 |
| 34 | MP0009278_abnormal_bone_marrow | 1.69434603 |
| 35 | MP0008260_abnormal_autophagy | 1.66559254 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.66124131 |
| 37 | MP0005451_abnormal_body_composition | 1.62941794 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.60455294 |
| 39 | MP0009764_decreased_sensitivity_to | 1.59412355 |
| 40 | MP0005310_abnormal_salivary_gland | 1.59065922 |
| 41 | MP0008469_abnormal_protein_level | 1.58610810 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.56684152 |
| 43 | MP0002722_abnormal_immune_system | 1.55719317 |
| 44 | MP0002429_abnormal_blood_cell | 1.55397760 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.43260238 |
| 46 | MP0003075_altered_response_to | 1.41603344 |
| 47 | MP0002132_abnormal_respiratory_system | 1.38622365 |
| 48 | MP0003866_abnormal_defecation | 1.31606304 |
| 49 | MP0003828_pulmonary_edema | 1.30306553 |
| 50 | MP0000858_altered_metastatic_potential | 1.28027473 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.26921423 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.24030689 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.20258487 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.20008102 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.19922702 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.19922702 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.19167985 |
| 58 | MP0000343_altered_response_to | 1.15760472 |
| 59 | MP0004883_abnormal_blood_vessel | 1.14255762 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.10821565 |
| 61 | MP0001853_heart_inflammation | 1.08723262 |
| 62 | MP0005166_decreased_susceptibility_to | 1.07681749 |
| 63 | MP0001851_eye_inflammation | 1.06578232 |
| 64 | MP0003690_abnormal_glial_cell | 1.03152138 |
| 65 | MP0008004_abnormal_stomach_pH | 1.02349439 |
| 66 | MP0004381_abnormal_hair_follicle | 0.99338912 |
| 67 | MP0001873_stomach_inflammation | 0.97061593 |
| 68 | MP0005164_abnormal_response_to | 0.89869532 |
| 69 | MP0003448_altered_tumor_morphology | 0.89528335 |
| 70 | MP0000490_abnormal_crypts_of | 0.87906127 |
| 71 | MP0009763_increased_sensitivity_to | 0.87549925 |
| 72 | MP0002166_altered_tumor_susceptibility | 0.86959944 |
| 73 | MP0001663_abnormal_digestive_system | 0.86431336 |
| 74 | MP0000604_amyloidosis | 0.85944091 |
| 75 | MP0009840_abnormal_foam_cell | 0.85648460 |
| 76 | MP0005390_skeleton_phenotype | 0.83479058 |
| 77 | MP0002933_joint_inflammation | 0.74986201 |
| 78 | MP0003045_fibrosis | 0.73199776 |
| 79 | MP0008874_decreased_physiological_sensi | 0.70418436 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.68508332 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.67814323 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.67537967 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.65618655 |
| 84 | MP0003795_abnormal_bone_structure | 0.63005569 |
| 85 | MP0000249_abnormal_blood_vessel | 0.62374254 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.59656181 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.59052742 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.58927127 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.57413337 |
| 90 | MP0002254_reproductive_system_inflammat | 0.56757104 |
| 91 | MP0003091_abnormal_cell_migration | 0.55379631 |
| 92 | MP0002006_tumorigenesis | 0.55175327 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.54594555 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.49537511 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49105294 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.48838566 |
| 97 | MP0002928_abnormal_bile_duct | 0.48370088 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.47508762 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.47469244 |
| 100 | MP0000609_abnormal_liver_physiology | 0.46309553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.10908593 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.19571826 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.17200813 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.83624829 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.45583530 |
| 6 | Myositis (HP:0100614) | 5.31505885 |
| 7 | Orchitis (HP:0100796) | 5.13296715 |
| 8 | Optic neuritis (HP:0100653) | 4.90385008 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.90385008 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.81375012 |
| 11 | Meningitis (HP:0001287) | 4.56981600 |
| 12 | Stomatitis (HP:0010280) | 4.55852617 |
| 13 | Obstructive lung disease (HP:0006536) | 4.45709983 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.45709983 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.19696014 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.16838970 |
| 17 | Cellulitis (HP:0100658) | 4.03573193 |
| 18 | Recurrent skin infections (HP:0001581) | 3.93004521 |
| 19 | Vasculitis (HP:0002633) | 3.84814997 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84135295 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.83123416 |
| 22 | Urticaria (HP:0001025) | 3.67355510 |
| 23 | Encephalitis (HP:0002383) | 3.63098807 |
| 24 | Increased IgE level (HP:0003212) | 3.60770498 |
| 25 | Gingivitis (HP:0000230) | 3.51960131 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.51477619 |
| 27 | Hypochromic microcytic anemia (HP:0004840) | 3.44463721 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.33651075 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.32800247 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.32450625 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.32450625 |
| 32 | Keratoconjunctivitis (HP:0001096) | 3.23760584 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 3.19614375 |
| 34 | Pulmonary infiltrates (HP:0002113) | 3.11887188 |
| 35 | Osteomyelitis (HP:0002754) | 3.08312592 |
| 36 | Hypochromic anemia (HP:0001931) | 3.08303049 |
| 37 | Recurrent viral infections (HP:0004429) | 3.06975378 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.96450931 |
| 39 | Hemoptysis (HP:0002105) | 2.94788253 |
| 40 | Chest pain (HP:0100749) | 2.90568275 |
| 41 | Increased IgM level (HP:0003496) | 2.88872337 |
| 42 | Lymphopenia (HP:0001888) | 2.88083726 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.86865568 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.85478706 |
| 45 | Recurrent pneumonia (HP:0006532) | 2.84587866 |
| 46 | Episodic fever (HP:0001954) | 2.76548872 |
| 47 | Recurrent bronchitis (HP:0002837) | 2.74369803 |
| 48 | Sepsis (HP:0100806) | 2.73519538 |
| 49 | Petechiae (HP:0000967) | 2.72665148 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.69550692 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.67025629 |
| 52 | Colitis (HP:0002583) | 2.65885161 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.63203739 |
| 54 | T lymphocytopenia (HP:0005403) | 2.59444043 |
| 55 | Anorexia (HP:0002039) | 2.58787689 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58179348 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58179348 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58179348 |
| 59 | Leukocytosis (HP:0001974) | 2.53378872 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.53117323 |
| 61 | Pulmonary embolism (HP:0002204) | 2.50987109 |
| 62 | Arterial thrombosis (HP:0004420) | 2.48540474 |
| 63 | Recurrent lower respiratory tract infections (HP:0002783) | 2.48406691 |
| 64 | Gingival bleeding (HP:0000225) | 2.45525873 |
| 65 | Abnormality of T cells (HP:0002843) | 2.43857186 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.42123491 |
| 67 | Epistaxis (HP:0000421) | 2.41159112 |
| 68 | Pustule (HP:0200039) | 2.38196141 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.37686300 |
| 70 | Purpura (HP:0000979) | 2.36690139 |
| 71 | Gangrene (HP:0100758) | 2.35828332 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.35611076 |
| 73 | IgM deficiency (HP:0002850) | 2.34775916 |
| 74 | Amyloidosis (HP:0011034) | 2.34544683 |
| 75 | Restrictive lung disease (HP:0002091) | 2.33383895 |
| 76 | Granulocytopenia (HP:0001913) | 2.32923634 |
| 77 | Loss of speech (HP:0002371) | 2.25734250 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.25210555 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.24652801 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.23946465 |
| 81 | Microcytic anemia (HP:0001935) | 2.22941380 |
| 82 | Skin ulcer (HP:0200042) | 2.19821565 |
| 83 | Abnormality of the peritoneum (HP:0002585) | 2.19774127 |
| 84 | Increased serum ferritin (HP:0003281) | 2.19706004 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.17376498 |
| 86 | Verrucae (HP:0200043) | 2.16607492 |
| 87 | Papilloma (HP:0012740) | 2.16607492 |
| 88 | Peritonitis (HP:0002586) | 2.14448008 |
| 89 | Chronic otitis media (HP:0000389) | 2.09598403 |
| 90 | Skin rash (HP:0000988) | 2.08418155 |
| 91 | Emphysema (HP:0002097) | 2.07346329 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.06734809 |
| 93 | Glomerulopathy (HP:0100820) | 2.04152937 |
| 94 | Abnormality of the endocardium (HP:0004306) | 2.02809405 |
| 95 | Abnormality of the pericardium (HP:0001697) | 2.02161441 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.02108339 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 1.99928291 |
| 98 | Arthralgia (HP:0002829) | 1.98400730 |
| 99 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.96787969 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94836635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.92249519 |
| 2 | MAP4K1 | 3.98392866 |
| 3 | IRAK4 | 3.87646942 |
| 4 | BLK | 3.44058501 |
| 5 | ERN1 | 3.10964676 |
| 6 | TYK2 | 2.90212854 |
| 7 | MAP2K3 | 2.65674807 |
| 8 | CSK | 2.57474895 |
| 9 | PRPF4B | 2.31250756 |
| 10 | TNK2 | 2.28511001 |
| 11 | FES | 2.14549147 |
| 12 | GRK6 | 2.08956572 |
| 13 | TAOK1 | 2.00327653 |
| 14 | MAP3K14 | 1.97024167 |
| 15 | MAP3K11 | 1.92568006 |
| 16 | SYK | 1.88202861 |
| 17 | BTK | 1.84732472 |
| 18 | FGR | 1.82640955 |
| 19 | TBK1 | 1.81552468 |
| 20 | IKBKE | 1.81367250 |
| 21 | JAK3 | 1.80884097 |
| 22 | ZAP70 | 1.78678117 |
| 23 | MAP3K3 | 1.74066721 |
| 24 | EPHB1 | 1.63096476 |
| 25 | HCK | 1.61711783 |
| 26 | SIK3 | 1.55405760 |
| 27 | LYN | 1.55366806 |
| 28 | TXK | 1.54282913 |
| 29 | MAP3K13 | 1.43765964 |
| 30 | CSF1R | 1.40036155 |
| 31 | TAOK2 | 1.38589843 |
| 32 | JAK1 | 1.30746537 |
| 33 | KIT | 1.29641344 |
| 34 | JAK2 | 1.27634200 |
| 35 | TESK2 | 1.25530847 |
| 36 | IKBKB | 1.24906811 |
| 37 | MATK | 1.21716331 |
| 38 | MAP3K1 | 1.19893735 |
| 39 | LCK | 1.17087068 |
| 40 | SIK2 | 1.15909442 |
| 41 | BMPR2 | 1.10520555 |
| 42 | MARK3 | 1.06911729 |
| 43 | KSR2 | 1.03219583 |
| 44 | IRAK3 | 0.96147127 |
| 45 | PRKD2 | 0.95136944 |
| 46 | YES1 | 0.92092396 |
| 47 | MARK2 | 0.86362721 |
| 48 | ITK | 0.85196243 |
| 49 | STK10 | 0.84800194 |
| 50 | TAOK3 | 0.84785472 |
| 51 | TRIB3 | 0.83282204 |
| 52 | SMG1 | 0.82942065 |
| 53 | CDK19 | 0.80907554 |
| 54 | PDK1 | 0.80586500 |
| 55 | IRAK1 | 0.79803556 |
| 56 | CDC42BPA | 0.79504241 |
| 57 | IRAK2 | 0.76407937 |
| 58 | TEC | 0.69939367 |
| 59 | PDPK1 | 0.69604240 |
| 60 | FYN | 0.68710238 |
| 61 | GRK7 | 0.68144736 |
| 62 | TGFBR2 | 0.67952734 |
| 63 | PTK6 | 0.65696179 |
| 64 | SIK1 | 0.64004135 |
| 65 | MAPK12 | 0.63352624 |
| 66 | PRKCQ | 0.59071422 |
| 67 | FGFR4 | 0.58970723 |
| 68 | MAP3K5 | 0.58057144 |
| 69 | LRRK2 | 0.51595520 |
| 70 | PIM1 | 0.51484928 |
| 71 | MAPK7 | 0.50420372 |
| 72 | HIPK2 | 0.48545454 |
| 73 | RPS6KC1 | 0.44956191 |
| 74 | RPS6KL1 | 0.44956191 |
| 75 | DYRK1B | 0.42965615 |
| 76 | STK11 | 0.40315268 |
| 77 | MAPKAPK2 | 0.39701990 |
| 78 | MAP3K6 | 0.38401060 |
| 79 | CHUK | 0.37573679 |
| 80 | PTK2B | 0.37489570 |
| 81 | EPHA3 | 0.37291122 |
| 82 | MAP3K8 | 0.37164165 |
| 83 | FGFR3 | 0.36840600 |
| 84 | RPS6KA6 | 0.36133259 |
| 85 | MAP3K7 | 0.36021556 |
| 86 | MAP2K6 | 0.34983339 |
| 87 | PRKCD | 0.34230129 |
| 88 | MOS | 0.34052688 |
| 89 | PRKCZ | 0.31552165 |
| 90 | DAPK2 | 0.31159118 |
| 91 | RAF1 | 0.30948056 |
| 92 | ALK | 0.30907989 |
| 93 | MAP2K4 | 0.30858727 |
| 94 | MAPK4 | 0.30774642 |
| 95 | PRKCH | 0.29987448 |
| 96 | MAPK11 | 0.28891434 |
| 97 | PRKG2 | 0.27440641 |
| 98 | ABL1 | 0.27064048 |
| 99 | SGK3 | 0.25602198 |
| 100 | CAMKK1 | 0.24647142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20029378 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.14490378 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.05102169 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.99226269 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.96959092 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.85554788 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.53504468 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.52638552 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34218980 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.30964432 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.27754877 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.22851060 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22204180 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19503710 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01462410 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.99649482 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.91795549 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.90566004 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89879032 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88982047 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72469917 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72226293 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.69815280 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65122780 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.64940349 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58856605 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55987903 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55402000 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55401646 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51585181 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.48995364 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45194136 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.44099546 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43889722 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39943239 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39036220 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37700801 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36821402 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25753879 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.20600553 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.17810208 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10134989 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.08690560 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.07844060 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.07756203 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.02466243 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02146324 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.99262687 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96385823 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96260640 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.90039763 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88078235 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85256465 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81001791 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.80574771 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73427556 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72749426 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70983091 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68709534 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65744342 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63474263 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63375586 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63365143 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.62906106 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62386814 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62294578 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61817595 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59806234 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58291835 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55862677 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54261952 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52586897 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48132464 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.47614370 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46687323 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44429037 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43469809 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42806967 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39037445 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37146335 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36702517 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35299087 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35254916 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34634309 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33872028 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33114881 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31646026 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31414553 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30658123 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29913897 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.29004531 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.28112988 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27200964 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25932201 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25606017 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23825191 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23238212 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22443030 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20704528 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20016956 |

